Baruch Scholars Program Offers Full Tuition for Students

Baruch Scholars  pic
Baruch Scholars

Steve Kanzer possesses more than two decades of experience in biotechnology and pharmaceutical development and serves as the chairman and CEO of Accredited Ventures in New York, New York. Prior to the launch of his career, Steve Kanzer graduated from Baruch College with a bachelor of business administration in accounting. He also was a Baruch Scholar.

The Baruch Scholars Program admits students entering into their first-year of college and supplies generous scholarships for in-state and out-of-state students. Designed to deliver supportive advisement and extensive academic opportunities, the program mitigates the financial burdens of college in order to help students focus on pursing their intellectual interests and career goals. Baruch Scholars participate in a wide range of activities, from studying abroad and conducting independent research to engaging the New York Community through civic responsibility and central issues. Furthermore, program advisors keep students informed about opportunities for professional development and additional scholarships.

In-state students will receive a full-tuition scholarship over a four-year period, while amounts for out-of-state students may vary. The program does not cover tuition for summer semesters. In order to graduate with honors from the program, students must also meet a number of general requirements, including enrollment as a full-time student and the completion of a minimum of 10 honor courses. Scholars must also commit to at least 15 hours of community service and attend one cultural event per semester.

To learn more about the Baruch Scholar Program, visit


New York University School of Law’s Root-Tilden-Kern Program

Root-Tilden-Kern Program pic
Root-Tilden-Kern Program

Steve Kanzer serves as chairman and CEO of Accredited Ventures, Inc., a venture capital group that focuses on the life science sector. Also active in charitable giving, Steve Kanzer gives to his alma mater, the New York University School of Law, which offers a number of public service scholarships through the Root-Tilden-Kern Program.

The Root-Tilden-Kern Program provides 20 scholarships per year to students who demonstrate academic excellence, dedication to public service, and leadership potential. During the program, scholarship recipients benefit from opportunities that prepare them for careers in public service, including mentoring and networking opportunities.

The scholarship covers full tuition for three years as well as living expenses for those with demonstrated need. The university also prioritizes diversity and strives to include applicants who come from families with socioeconomic disadvantages.

Since its beginning in 1951, the Root-Tilden-Kern Program has produced graduates that have gone on to become some of the most influential public service attorneys. To learn more about the program, visit

Memorial Sloan Kettering Cancer Center Gives Results of Sarcoma Drug

Memorial Sloan Kettering Cancer Center (MSKCC) Image:
Memorial Sloan Kettering Cancer Center (MSKCC)


A graduate of New York University’s School of Law, Steve Kanzer works as chairman and chief executive officer of Accredited Ventures, Inc. located in New York City. A philanthropic individual, Steve Kanzer supports several local endeavors, including the Memorial Sloan Kettering Cancer Center (MSKCC).

Founded in 1884, the MSKCC is the world’s oldest and largest private cancer center. Since then, the New York City center is one of 45 National Cancer Institute-designated comprehensive cancer centers. For the past 25 years, U.S. News and World Report has named the center among one of the top two national hospitals for cancer care. As of 2016, the center has 471 inpatient beds and a 72,000-square-foot surgical center.

In June 2016, MSKCC announced the results of a study pertaining to a new drug given to those with advanced soft tissue sarcoma. The multicenter phase II trial evaluated the safety and efficacy of Olaratumab in conjunction with doxorubicin chemotherapy. According to William Tap, MD, who serves as the chief of the sarcoma medical oncology service at MSKCC and corresponding author of the study, the drug extended the patients’ lives by almost one year. Based on these results, the Federal Drug Administration (FDA) has granted the drug breakthrough therapy status, which means the FDA will expedite the development of the drug.

Zicklin School of Business

Zicklin School of Business pic
Zicklin School of Business

Prior to beginning a career as a biotech venture capitalist, Steve H. Kanzer attended the New York University School of Law in New York City, New York where he received a JD in 1988. Steve Kanzer also attended Baruch College in New York City, New York, where he received a bachelor’s degree in business administration in accounting in 1985.

Baruch College is a part of The City University of New York (CUNY) system and features the Zicklin School of Business. The Zicklin School of Business offers an executive MBA and MS program to help business students along with business professionals and potential executives who are looking to improve their skills and business potential.

The Zicklin School of Business’ offerings include an executive MS in Finance that is designed to help students think strategically while making financial decisions and knowing how to communicate persuasively and effectively. Many alumni have gone on to achieve positions at major companies such as Barclay’s, Neuberger Berman, Citigroup, and JP Morgan Chase.

Memorial Sloan Kettering Cancer Center Launches MSK Direct Program

Memorial Sloan Kettering Cancer Center pic
Memorial Sloan Kettering Cancer Center

For more than 15 years, Steve H. Kanzer has served as chairman and CEO of Accredited Ventures Inc., a New York City-based investment firm focused on life sciences. He was also the principal executive of Adeona Pharmaceuticals based out of Ann Harbor, MI. Alongside his work in investment banking, Steve Kanzer supports several academic and non-profit organizations, including Memorial Sloan Kettering Cancer Center (MSK).

In a recently released statement, MSK announced the launch of its new program MSK Direct, which will help more patients access high-quality health care following a cancer diagnosis. Through the program, MSK is collaborating with its employer partners to make it easier for their employees to get initial or follow-up care at the institution.

Employees whose companies participate in the free program have access to a team of experienced nurses, social workers, and care providers who will help them gather medical records, schedule doctor’s appointments, and coordinate other services related to their ongoing care. The team of professionals will work with the employees and their families throughout their experience at MSK to help ensure that they receive the support and medical services they need to regain their health.

Still in the early stages, MSK Direct is currently available through six of MSK’s employer partners, including CBS and the Port Authority of New York and New Jersey. To learn more about the program, visit

Tennis Tiebreak Debuts at US Open


US Open pic
US Open

As chairman and chief executive officer of joint venture capital group Accredited Ventures, Inc., Steve Kanzer has established and served in various leadership capacities at dozens of companies. Away from his work in investment banking, Steve Kanzer enjoys staying active through tennis.

In 1970 the US Open became the first major tennis tournament to make use of tiebreak scoring. Prior to the event, all sets of professional men’s and women’s tennis were played under advantage scoring, meaning players had to secure six games with a two-game margin. Following these rules, a set could range from a scoreline of 6-0 to 12-10 or higher. With the introduction of the tiebreak, players knotted at six games all would enter into a sudden-death situation that awarded the set to the first player to win seven points, assuming a two-point margin has been achieved.

A number of tiebreaks were played at the 1970 US Open, none more memorable than a third-set breaker during the men’s final between Tony Roche and Ken Rosewall. With the match tied at one set apiece, Roche and Rosewall contested the first ever tiebreak in a major final. Rosewall won the tiebreak and went on to win the next set 6-3, claiming his second US Open title and first in 14 years. Five years later the US Open approved tiebreak scoring in all sets, including decisive sets, for both men and women.

Connecting Two Seemingly Contradicting Theories in Physics

Theoretical Physics pic
Theoretical Physics

An alumnus of the New York University School of Law, Stever Kanzer functions as the CEO and chairman of Accredited Ventures, Inc., in New York City. In his free time, Steve Kanzer pursues a variety of interests, including in theoretical physics.

Theoretical physics encompasses a multitude of mysteries, including the seeming contradiction of the best theories that explain the universe: general relativity and quantum mechanics. Although the theories hold up independently of one another, the math of each fails to support the other when combined.

In 2013, Stanford theoretical physicist Leonard Susskind developed a new equation that attempts to link the two theories using the concept of Einstein-Rosen bridges, also known as wormholes. Comprised of papers rather than numbers, the equation harmonizes the positions taken in two papers from 1935 that describe wormholes and quantum entanglement. Specifically, Dr. Susskind asserts that the papers are actually describing the same thing.

Dr. Susskind is not alone in advocating for this idea; earlier this year, a team of scientists from Caltech formulated a similar hypothesis, stating that changes in quantum states have a connection to curves in spacetime geometry.